Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 2736-2738, November 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasselberger, F. X.
Right arrow Articles by Pennington, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasselberger, F. X.
Right arrow Articles by Pennington, S. N.

The Preparation of Insoluble, Matrix-supported Derivatives of Asparaginase for Use in Cancer Therapy1

Francis X. Hasselberger, Harry D. Brown, Swaraj K. Chattopadhyay, Adaline N. Mather, Roman O. Stasiw, Anil B. Patel and Sam N. Pennington

Biochemistry Section, Cancer Research Center, Columbia, Missouri 65201, and Travenol Laboratories, Inc., Morton Grove, Illinois 60053

Four methods are described for the preparation of enzymically active, water-insoluble derivatives of the antineoplastic enzyme asparaginase from Escherichia coli B. All methods lead to covalent bond formation, and three of the derivatives are more stable at 37° than free enzyme in solution. Derivatives prepared by the Woodward's reagent method are slightly less stable than free enzyme at 37°. The materials are suggested for use in an extracorporeal filter.

1 This work was supported by Travenol Division, Baxter Laboratories, Morton Grove, Ill.

Received 6/ 4/70. Accepted 7/28/70.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.